Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma

Ghassan K. Abou-Alfa, Robert Mayer, Alan P. Venook, Allison F. O'Neill, Muhammad S. Beg, Michael LaQuaglia, Peter T. Kingham, Rachel Kobos, Olca Basturk, Cameron Brennan, Adam Yopp, James J. Harding, Stephen Leong, John Crown, Emir Hoti, Gregory Leonard, Michele Ly, Mikaela Bradley, Emily Valentino, David MarkowitzAlexander Zukiwski, Ken Ren, John D. Gordan

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences